The House recently approved HR 3204, a bill that would give the FDA broad new authority to regulate compounding pharmacies.  Now the bill is before the Senate. It is anticipated that this bill will be fast tracked to be voted on October 28th.
 
The legislation is intended to address concerns about the safety of compounded medications – since an outbreak of fungal meningitis last fall killed 55 people and sickened more than 700 nationally.  That outbreak was directly attributable to a contaminated steroid produced by a compounding manufacturer in Massachusetts.
 
We are providing you a link in this email with reference to S959, that you as the physician can use, as well as sending it to your patients, friends and family to send an email to your congressional constitutes in your district.
When you click on the link  http://www.protectmycompounds.com/  it will take you to a website about the bill. Click on “Take Action”. This link will provide you with the links if you are a prescriber and patient.
 
S959